Summary
74 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 14% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
- Out of every 100 USD of revenue, 16 USD is left as net profit.
- It has raised its dividend 7 years in a row and pays out only 28% of profit.
What to watch
None of the indicators we track raises a caution right now.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 13.9 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue fell by 0.4% a year over 5 years. Over the last 3 years it grew by 8.1% a year. Earnings per share grew by 14% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 3.1 USD
- Sales and administration 77 USD
- Taxes and other 3.5 USD
- Net profit 16 USD
Net profit, industry median (Insurance - Life) 11 USD
Out of every 100 USD of revenue, 16 USD is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 2.01%
- Paid out of profit
- 28%
- Raised in a row
- 7 years
You receive $1.88 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 16
- Hold 10
- Sell 1
Today's price within the analysts' price targets
The average target of $104.22 is 12% above today's price. 59% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2024By product
- Health Solutions Segment 78%
- Investment Management Segment 22%
By region
The company reports no revenue by region.
Health Solutions Segment brings in 78% of revenue.
Segments in detail